INmune Bio, Inc. (INMB) Dividend Yield, History & Forecast
INmune Bio, Inc. (INMB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Capital Market. market capitalization is approximately $32M.
Frequently Asked Questions about INmune Bio, Inc. (INMB)
Is INmune Bio, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is INmune Bio, Inc. in?▾
INmune Bio, Inc. (INMB) operates in the Healthcare sector, specifically the Biotechnology industry.
